Association of obesity with COVID-19 severity and mortality: an updated systemic review, meta-analysis, and meta-regression
R Singh, SS Rathore, H Khan, S Karale… - Frontiers in …, 2022 - frontiersin.org
Background Obesity affects the course of critical illnesses. We aimed to estimate the
association of obesity with the severity and mortality in coronavirus disease 2019 (COVID …
association of obesity with the severity and mortality in coronavirus disease 2019 (COVID …
[HTML][HTML] Pandemics throughout the history
As we move amidst the coronavirus disease 2019 (COVID-19) pandemic, we have
witnessed tremendous distress, death, and turmoil of everyday life for more than one year …
witnessed tremendous distress, death, and turmoil of everyday life for more than one year …
Myocarditis associated with Covid‐19 disease: a systematic review of published case reports and case series
Background Covid‐19 is an extremely contagious illness caused by the severe acute
respiratory syndrome (SARS‐CoV‐2) virus. The cardiac involvement in such a public health …
respiratory syndrome (SARS‐CoV‐2) virus. The cardiac involvement in such a public health …
[HTML][HTML] Vaccine development throughout history
The emergence of the coronavirus disease 2019 (COVID-19) pandemic has made us
appreciate how important it is to quickly develop treatments and save lives. The race to …
appreciate how important it is to quickly develop treatments and save lives. The race to …
Therapeutic effectiveness and safety of repurposing drugs for the treatment of COVID-19: position standing in 2021
COVID-19, transmitted by SARS-CoV-2, is one of the most serious pandemic situations in
the history of mankind, and has already infected a huge population across the globe. This …
the history of mankind, and has already infected a huge population across the globe. This …
Small molecule angiotensin converting enzyme inhibitors: A medicinal chemistry perspective
W Zheng, E Tian, Z Liu, C Zhou, P Yang… - Frontiers in …, 2022 - frontiersin.org
Angiotensin-converting enzyme (ACE), a zinc metalloprotein, is a central component of the
renin–angiotensin system (RAS). It degrades bradykinin and other vasoactive peptides …
renin–angiotensin system (RAS). It degrades bradykinin and other vasoactive peptides …
Prevalence and clinical outcomes of pleural effusion in COVID‐19 patients: A systematic review and meta‐analysis
SS Rathore, N Hussain, AH Manju… - Journal of Medical …, 2022 - Wiley Online Library
Observational studies indicate that pleural effusion has an association with risk and the
clinical prognosis of COVID‐19 disease; however, the available literature on this area is …
clinical prognosis of COVID‐19 disease; however, the available literature on this area is …
Renin–angiotensin–aldosterone inhibitors and COVID-19 infection
V Tsampasian, N Corballis, VS Vassiliou - Current Hypertension Reports, 2022 - Springer
Abstract Purpose of Review This review summarises the literature data and provides an
overview of the role and impact of the use of renin–angiotensin–aldosterone system (RAAS) …
overview of the role and impact of the use of renin–angiotensin–aldosterone system (RAAS) …
Effect of continuing the use of renin–angiotensin system inhibitors on mortality in patients hospitalized for coronavirus disease 2019: a systematic review, meta …
Q Liu, W Fu, C Zhu, Z Ding, B Dong, B Sun… - BMC infectious …, 2023 - Springer
Background The effect of angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin
receptor blockers (ARBs) on mortality was preliminarily explored through the comparison of …
receptor blockers (ARBs) on mortality was preliminarily explored through the comparison of …
An umbrella review and meta‐analysis of renin–angiotensin system drugs use and COVID‐19 outcomes
A Kurdi, T Mueller, N Weir - European journal of clinical …, 2023 - Wiley Online Library
Background Despite the availability of extensive literature on the effect of angiotensin‐
converting enzyme inhibitors (ACEIs)/angiotensin‐receptor blockers (ARBs) on COVID‐19 …
converting enzyme inhibitors (ACEIs)/angiotensin‐receptor blockers (ARBs) on COVID‐19 …